AAAAAA

   
Results: 1-10 |
Results: 10
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulatingdendritic cells, IL-12 and endothelin-1
Authors: Lissoni, P Malugani, F Bonfanti, A Bucovec, R Secondino, S Brivio, F Ferrari-Bravo, A Ferrante, R Vigore, L Rovelli, F Mandala, M Viviani, S Fumagalli, L Gardani, GS
Citation: P. Lissoni et al., Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulatingdendritic cells, IL-12 and endothelin-1, J BIOL REG, 15(2), 2001, pp. 140-144
Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients
Authors: Lissoni, P Fumagalli, E Malugani, F Ardizzoia, A Bucovec, R Tancini, G Gardani, GS
Citation: P. Lissoni et al., Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients, J BIOL REG, 15(2), 2001, pp. 163-165
Stimulation of IL-18 secretion by IL-2 in patients with advanced cancer
Authors: Lissoni, P Rovelli, F Vellani, D Malugani, F Bucovec, R Chapovalenko, L Fumagalli, E Gardani, G
Citation: P. Lissoni et al., Stimulation of IL-18 secretion by IL-2 in patients with advanced cancer, INT J B MAR, 16(2), 2001, pp. 146-147
Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2
Authors: Lissoni, P Mandala, M Curigliano, G Ferretti, G Moro, C Ardizzoia, A Malugani, F Tancini, G Tisi, E Arrigoni, C Barni, S
Citation: P. Lissoni et al., Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2, ONCOL-BASEL, 60(4), 2001, pp. 308-312
Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease
Authors: Lissoni, P Brivio, F Rovelli, F Fumagalli, G Malugani, F Vaghi, N Secondino, S Bucovec, R Gardani, GS
Citation: P. Lissoni et al., Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease, J BIOL REG, 14(4), 2000, pp. 275-277
Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer
Authors: Lissoni, P Fugamalli, E Malugani, F Ardizzoia, A Secondino, S Tancini, G Gardani, GS
Citation: P. Lissoni et al., Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer, INT J B MAR, 15(4), 2000, pp. 308-311
Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer
Authors: Lissoni, P Brivio, F Ferrante, R Vigore, L Vaghi, M Fumagalli, E Bucovec, R Malugani, F Fumagalli, L
Citation: P. Lissoni et al., Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer, INT J B MAR, 15(1), 2000, pp. 22-25
Decreased toxicity and increased efficacy of cancer chemotherapy using thepineal hormone melatonin in metastatic solid tumour patients with poor clinical status
Authors: Lissoni, P Barni, S Mandala, M Ardizzoia, A Paolorossi, F Vaghi, M Longarini, R Malugani, F Tancini, G
Citation: P. Lissoni et al., Decreased toxicity and increased efficacy of cancer chemotherapy using thepineal hormone melatonin in metastatic solid tumour patients with poor clinical status, EUR J CANC, 35(12), 1999, pp. 1688-1692
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study
Authors: Lissoni, P Tancini, G Paolorossi, F Mandala, M Ardizzoia, A Malugani, F Giani, L Barni, S
Citation: P. Lissoni et al., Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study, J PINEAL R, 26(3), 1999, pp. 169-173
Endocrinological study of the dopaminergic regulation of prolactin releasein metastatic breast cancer
Authors: Mandala, M Lissoni, P Ardizzoia, A Barni, S Rovelli, F Confalonieri, G Malugani, F Moro, C Fumagalli, G Giani, L Tancini, G
Citation: M. Mandala et al., Endocrinological study of the dopaminergic regulation of prolactin releasein metastatic breast cancer, TUMORI, 85(6), 1999, pp. 494-497
Risultati: 1-10 |